Cancer Think Tank 2.0

Researchers, oncologists, biostatisticians and others in the cancer community gather to discuss the latest developments in personalized cancer treatments. Dr. Anthony Letai from Dana-Farber Cancer Institute will present his work on developing novel drugs and using a personalized functional assay for predicting which types of cancer might respond best to them. SEngine Precision Medicine’s Dr. Carla Grandori will introduce her company’s P.A.R.I.S. test which employs high-throughput screening, genetic sequencing, and bioinformatics to propose individualized treatments for cancer patients. Oregon Health Science University’s Dr. Marc Loriaux will speak on OHSU’s ongoing progress in this field. Includes a tour of LabCyte’s Echo Acoustic Liquid Handler. Reception and networking to follow.